Lipid Disorders
From the Journals
USPSTF maintains ‘insufficient evidence’ for lipid disorder screenings in kids and teens
“There’s just not enough evidence to determine whether or not screening all children for high cholesterol improves their heart health into...
News
FDA expands inclisiran statin-adjunct indication to include primary prevention
The indications now include patients taking statins for primary dyslipidemia who have high-risk comorbidities such as diabetes but who do not have...
Latest News
SAFE algorithm detects liver disease in general population
Scoring system was developed and validated to detect clinically significant (greater than stage 2) fibrosis in patients with NAFLD in primary care...
Conference Coverage
‘Striking’ benefit of lipid lowering in primary prevention
“If patients can’t tolerate a statin, then treat them with bempedoic acid. The bottom line is that these patients just need to be treated.”
Latest News
‘Exciting time for NASH’ with resmetirom phase 3 results
Two doses of resmetirom met the primary endpoints of NASH resolution and no worsening of fibrosis on liver biopsy.
Latest News
NAFLD increases risk for severe infections
Physicians should assess their patients’ vaccination status and seek to control modifiable risk factors, such as diabetes.
Conference Coverage
High Lp(a) tied to higher coronary plaque volume, progression
This could explain the greater risk for major adverse cardiovascular events seen in patients with high Lp(a) levels.
From the Journals
Plant-based diet tied to healthier blood lipid levels
“This work represents a well-conducted analysis of 30 clinical trials involving over two thousand participants and highlights the value of a...
From the Journals
Diabetes, cholesterol meds use drops after bariatric surgery
Undergoing bariatric surgery was associated with a substantial and long-lasting reduction in the use of lipid-lowering and antidiabetic...
Conference Coverage
Half of deaths from homozygous FH occur before age 32 years
“We should do something to prolong the lives of those people,” because the current results are “terrifying.”
From the Journals
Statins appear to guard against liver disease progression
This study “continues the theme that cholesterol-lowering statins are good for a lot more things than just lowering cholesterol.”